Sight Sciences, Inc. (SGHT)
NASDAQ: SGHT · Real-Time Price · USD
4.200
-0.050 (-1.18%)
Aug 14, 2025, 11:32 AM - Market open
Sight Sciences Revenue
Sight Sciences had revenue of $19.56M in the quarter ending June 30, 2025, a decrease of -8.45%. This brings the company's revenue in the last twelve months to $76.30M, down -3.89% year-over-year. In the year 2024, Sight Sciences had annual revenue of $79.87M, down -1.47%.
Revenue (ttm)
$76.30M
Revenue Growth
-3.89%
P/S Ratio
2.84
Revenue / Employee
$353,255
Employees
216
Market Cap
219.94M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
SGHT News
- 6 days ago - Sight Sciences, Inc. (SGHT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance - GlobeNewsWire
- 15 days ago - Sight Sciences Announces the Results of a Cost-Utility Analysis Demonstrating Cost Savings and Greater Health Utility with the TearCare® System Compared to Cyclosporine 0.05% for Treating Meibomian Gland Disease-Associated Dry Eye Disease - GlobeNewsWire
- 16 days ago - Sight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare® Procedure for the Treatment of Dry Eye Disease - GlobeNewsWire
- 20 days ago - Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 3 months ago - Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th - GlobeNewsWire
- 3 months ago - Sight Sciences, Inc. (SGHT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance - GlobeNewsWire